Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials. (2019)
Attributed to:
Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunctio
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13054-019-2446-1
PubMed Identifier: 31053084
Publication URI: http://europepmc.org/abstract/MED/31053084
Type: Journal Article/Review
Volume: 23
Parent Publication: Critical care (London, England)
Issue: 1
ISSN: 1364-8535